Neuralink announced that it has successfully implaed its brain chip inside a human brain for the first time. This chip is designed to improve the brain activity of paties suffering from motor paralysis.
This company was recely able to get a license to impla a brain chip from the US Food and Drug Administration (FDA), and apparely many people have declared their readiness to receive this chip, and today the first volueer successfully received it.
The Neuralink brain chip is supposed to provide a way for computers to connect with the human brain, and all the activities of this chip can be corolled and monitored. This chip will actually be a type of brain-computer user ierface that will place tiny electrodes inside our brain to create a connection between the brain and the computer.
In 2019, Neuralink claimed that it was able to corol a monkey through a computer by implaing a sensor inside its brain. This company has even published videos that show that monkeys can play video games or speak some words through these sensors and computer corol.
Of course, Novalink had not been able to perform these experimes on humans and it seemed that the risk of this work is very high for humans. The company was supposed to do this in 2020 but has delayed it every time.
Apparely, the pressure of the media and the dangers that this work may cause to humans have preveed it from being done. Elon Musk said during a conference that Neuralink is preparing for human testing of his brain chip, and it will probably be done on a human in early 2024.
The said chip is placed in the patie's brain by a specialized robot. Unlike Synchron's Sterode technology, which is performed without surgery, the Neuralink technology requires robotic surgery. This technology converts the brain's electrical signals io digital commands and acts as an iermediary between the mind and the computer.
Elon Musk believes that the Neuralink brain chip is completely safe and will not pose a risk to paties. He even said that he is willing to put it inside his child's brain.
